1st Quarter - Amendment — TODD STRATEGY GROUP for CELGENE CORPORATION (2019)

Firm

TODD STRATEGY GROUP

Client

CELGENE CORPORATION

Income

$50,000

Expenses

—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 22, 2019	$40,000	Replaced
1st Quarter - Amendment (this page)	Apr 23, 2019	$50,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare/Medicaid Issues. Medicare reimbursement for transformative therapies. CREATES Act and FDA REMS reform. President's American Patients First Blueprint.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD	Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

User Fee Agreement Reauthorization.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	—
DANIEL M TODD	—

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.